Kymera Therapeutics, Inc. (KYMR)

84.26 +0.26 (+0.32%) USD  |  NASDAQ  |  Dec 22, 14:38
More

Kymera Therapeutics EPS Diluted from Continuing Operations (Quarterly)

EPS Diluted from Continuing Operations (Quarterly) Chart

View EPS Diluted from Continuing Operations (Quarterly) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Continuing Operations (Quarterly) Benchmarks

View EPS Diluted from Continuing Operations (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Cytokinetics, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade